Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AARP Medicare Rx “Reserve” Proposal Seeks To Bypass Cost Debate

Executive Summary

AARP is suggesting tapping the Medicare trust fund surplus as a way to finesse the cost-estimate barrier to a comprehensive prescription drug benefit

You may also be interested in...



Medicare Rx Premium Acceptance Polls Do Not Reflect “Reality” – Thomas

Concerns that high premiums will discourage seniors from enrolling in a Medicare drug program will not be borne out when seniors are actually presented with a viable drug benefit, House Ways & Means Committee Chairman Bill Thomas (R-Calif.) declared

Medicare Rx Premium Acceptance Polls Do Not Reflect “Reality” – Thomas

Concerns that high premiums will discourage seniors from enrolling in a Medicare drug program will not be borne out when seniors are actually presented with a viable drug benefit, House Ways & Means Committee Chairman Bill Thomas (R-Calif.) declared

CBO Medicare Rx Costs: Thomas Plan Is $155 Bil. Under House Set-Aside

The House leadership will have approximately $155 bil. to use under this year's budget resolution to enhance its Medicare Rx proposal, according to the Congressional Budget Office's revised cost estimates for drug benefit proposals

Related Content

UsernamePublicRestriction

Register

PS039389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel